DEL ZINGARO, Michele
 Distribuzione geografica
Continente #
EU - Europa 16.030
NA - Nord America 8.943
AS - Asia 5.622
SA - Sud America 984
AF - Africa 179
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 7
Totale 31.784
Nazione #
IT - Italia 9.538
US - Stati Uniti d'America 8.755
SG - Singapore 2.515
UA - Ucraina 1.436
IE - Irlanda 976
SE - Svezia 920
RU - Federazione Russa 846
BR - Brasile 782
CN - Cina 768
HK - Hong Kong 695
VN - Vietnam 608
FR - Francia 509
DE - Germania 473
FI - Finlandia 351
KR - Corea 299
GB - Regno Unito 271
NL - Olanda 260
IN - India 147
TR - Turchia 123
CA - Canada 100
CH - Svizzera 89
PL - Polonia 87
AR - Argentina 77
BD - Bangladesh 68
BE - Belgio 60
MA - Marocco 59
PK - Pakistan 58
IQ - Iraq 53
MX - Messico 50
ES - Italia 41
CO - Colombia 40
ZA - Sudafrica 37
UZ - Uzbekistan 36
ID - Indonesia 35
JP - Giappone 35
RO - Romania 33
AT - Austria 29
SA - Arabia Saudita 25
EC - Ecuador 24
LB - Libano 20
TN - Tunisia 19
CZ - Repubblica Ceca 18
EG - Egitto 18
MY - Malesia 18
LT - Lituania 17
EU - Europa 16
VE - Venezuela 16
PH - Filippine 13
NP - Nepal 12
CL - Cile 11
IR - Iran 11
UY - Uruguay 11
GR - Grecia 10
AE - Emirati Arabi Uniti 9
CR - Costa Rica 9
SM - San Marino 9
AL - Albania 8
BG - Bulgaria 8
DZ - Algeria 8
HU - Ungheria 8
IL - Israele 8
PY - Paraguay 8
BO - Bolivia 7
KZ - Kazakistan 7
AU - Australia 6
DO - Repubblica Dominicana 6
JO - Giordania 6
KE - Kenya 6
SK - Slovacchia (Repubblica Slovacca) 6
TH - Thailandia 6
JM - Giamaica 5
KG - Kirghizistan 5
OM - Oman 5
PE - Perù 5
PS - Palestinian Territory 5
AZ - Azerbaigian 4
ET - Etiopia 4
GE - Georgia 4
PT - Portogallo 4
CI - Costa d'Avorio 3
DK - Danimarca 3
EE - Estonia 3
GY - Guiana 3
HR - Croazia 3
KH - Cambogia 3
LY - Libia 3
PA - Panama 3
RS - Serbia 3
SN - Senegal 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AF - Afghanistan, Repubblica islamica di 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BZ - Belize 2
CY - Cipro 2
GA - Gabon 2
GH - Ghana 2
HN - Honduras 2
Totale 31.738
Città #
Singapore 1.734
Chandler 1.362
Milan 1.096
Dublin 969
Jacksonville 698
Hong Kong 689
San Mateo 597
San Jose 561
Rome 532
Ashburn 484
Boardman 387
Dong Ket 312
Seoul 299
Santa Clara 292
Florence 273
Moscow 259
Perugia 253
Medford 252
Princeton 249
Turin 241
Lauterbourg 212
Wilmington 192
Ann Arbor 172
Naples 170
Des Moines 158
Beijing 147
Andover 144
Munich 125
Altamura 119
Piscataway 117
Los Angeles 110
Ho Chi Minh City 106
New York 94
Lawrence 90
Bologna 81
Genoa 78
Helsinki 76
Shanghai 76
Saint Petersburg 71
The Dalles 67
Brescia 65
Izmir 62
Hanoi 60
Redwood City 60
Orem 59
São Paulo 57
Brussels 56
Verona 53
Turku 47
Dallas 46
Norwalk 45
Palermo 43
Bari 42
Woodbridge 42
Ottawa 41
Pescara 40
Torino 40
Bergamo 39
Ouezzane 38
Chennai 37
Warsaw 37
Napoli 36
Brooklyn 35
Frankfurt am Main 35
Chicago 33
Stockholm 33
Catania 32
Tokyo 32
Como 31
Council Bluffs 31
Monza 31
Redmond 30
Padova 28
Baghdad 26
Columbus 26
Falls Church 26
Montreal 25
Rio de Janeiro 25
Cagliari 24
Parma 24
Tashkent 24
Johannesburg 23
Paris 23
Atlanta 22
Mumbai 22
Scandiano 22
Houston 21
London 21
Manchester 21
Lucca 20
Amsterdam 19
Belo Horizonte 19
Bucharest 19
Livorno 19
Reggio Emilia 19
Denver 18
Modena 18
Nuremberg 18
Phoenix 18
Auburn Hills 17
Totale 15.919
Nome #
Il ruolo della TURB II-Look nei tumori superficiali della vescica: revisione sistematica della letteratura e meta-analisi 7.474
BCG vs Gemcitabina per la terapia endovescicale del carcinoma uroteliale ad alto rischio. Studio prospettico randomizzato. 1.635
Ruolo della colposospensione sec.Burch associata a ricostruzione integrale per via addominale in pazienti continenti e incontinenti affette da prolasso urogenitale avanzato. Rivalutazione a lungo termine di 2 studi clinici randomizzati 398
1 hour pad test ha un basso valore predittivo nella diagnosi dell’incontinenza urinaria femminile 392
Ruolo dell’ecografia nella valutazione delle complicanze della chirurgia pelvica con impiego di protesi 275
DIAGNOSI ECOGRAFICA DI DEFICIT SFINTERICO URETRALE NELLA DONNA 260
La correzione del prolasso urogenitale mediante la colposacropessia e la isterocolposacropessia 247
1-hour pad test has low predictive value in the diagnosis of women with urinary incontinence 238
Abdominal surgery for uterovaginal prolapse: sacropexy vs hysterocolposacropexy 166
SLING MEDIOURETRALE RETROPUBICA E TRANSOTTURATORIA A CONFRONTO NELLE PAZIENTI CON INCONTINENZA URINARIA MISTA NON RESPONSIVA A TERAPIA CONSERVATIVA 160
Bacillus Calmette-Guérin versus Gemcitabine for intravesical therapy in high-risk superficial bladder cancer: a randomised prospective study 158
Renal Artery Embolization Before Radical Nephrectomy for Complex Renal Tumour: Which are the True Advantages? 146
Abdominal pelvic floor reconstruction with uterus preservation 139
A personal surgical experience with orthotopic ileal neo-bladder reconstruction: long term functional results 138
Performance of incontinence impact questionnaire (IIQ) in italian population according to educational status 137
Abdominal integral pelvic reconstruction plus or minus Burch colposuspension in the treatment of severe uro-genital prolapse associated to urinary incontinence. A RCT with a mid-term follow up 135
Effects of Botulinum-A toxin intravesical injections on bladder hypersensitive disorders: a pilot study 131
Is surgical outcome at risk during post-graduated educational courses for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) repair? A case control study 127
Long-term outcome of anti-incontinence procedure during Pelvic Organ Prolapse repair in patients with or without urinary incontinence: results from two randomized surgical trials 125
Colovesical fistula: review on conservative management, surgical techniques and minimally invasive approaches 123
Fournier's gangrene secondary to locally advanced prostate cancer: case report and review of the Literature 123
Influence of COVID-19 pandemic on stress levels of urologic patients 123
Prulifloxacin vs Phosphomycin: Prophylaxis in patients with recurrent UTI. Preliminary results of a randomized multi-centre study 122
Comparing PUMA with other advanced urodynamic methods in the diagnosis of bladder outlet obstruction in men with benign prostatic hypertrophy 121
A Camey II Modified Neobladder: Long-Term Complications And Functional Results. 121
Anastomosi microchirurgiche e studio eco-color-Doppler 121
Leiomioma mixoide vaginale parauretrale 120
Advanced Urodynamic methods in the diagnosis of bladder outlet obstruction in females 119
Holmium:YAG Laser for the Treatment of Genital and urethral Warts: Multicentre Prospective Evaluation of Safety and Efficacy 118
Diagnostic performance of the Bladder EpiCheck methylation test and photodynamic diagnosis-guided cystoscopy in the surveillance of high-risk non-muscle invasive bladder cancer: A single centre, prospective, blinded clinical trial 118
Il Q-tip test vs ecografia nella diagnosi di ipermobilità uretrale: nostra esperienza 117
Valutazione ecografica del deficit sfinterico uretrale: nostra esperienza 116
Uterus preservation vs hysterectomy during sacropexy 116
Valsalva Leak Point pressure e successo della uretropessi retropubica nelle pazienti affette da severo prolasso urogenitale. Dati preliminari 115
Affidabilità dell'ecografia nella diagnosi dell'ipermobilità uretrale: dati preliminari 115
Fournier's Gangrene and Intravenous Drug Abuse: an Unusual Case Report and Review of The Literature 115
Safety and efficacy of a modified technique of holmium laser enucleation of the prostate (Holep) for benign prostatic hyperplasia 115
Test-retest of Valsalva leak point pressure 114
Body mass Index and urinary symptoms in women 114
Determinazione dei livelli vescicali tissutali di isoprostano 8-epi-PGF2 alfa in pazienti con disfunzioni vescico-sfinteriche ad elevato stress ossidativo 114
La colposospensione associata a Ricostruzione integrale del pavimento pelvico. 113
Management of healing abnormalities after abdominal pelvic organ prolapse repair 112
Diagnosi ecografica di iperattività detrusoriale: nostra esperienza 112
Prospettiva di impiego della RMN nel follow-up dell’operato di amputazione addomino-perineale per carcinomale rettale 112
Botulinum a toxin intravesical injections for painful bladder syndrome: impact upon pain, psychological functioning and quality of life 111
Sacropexy with uterine conservation: results after 5 years 111
Bladder tissue levels of nerve growth factor in patients with benign prostatic hyperplasia and detrusor overactivity treated with tamsulosin. 110
.“Semeiotica urologica” Manuale di Chirurgia Monduzzi Editore 109
Long-Term follow-up uterus sparing surgery for pelvic organ prolapse (POP) 109
Evaluation of Surgical Site Infection in Mini-invasive Urological Surgery 109
New evolution of robotic radical prostatectomy: A single center experience with PERUSIA technique 109
Ruolo dell’ESWL nella terapia della litiasi complessaCongresso Nazionale SIU 108
Early recovery of pre-RARP latency time in uroflow stop test with EMG may predict early erectile function restoration 108
Somministrazione intradetrusoriale di tossina botulinica A in pazienti con iperattività detrusoriale e vescica iperattiva dovute a M. di Parkinson ed Atrofia Multisistemica 107
A PROSPECTIVE RANDOMIZED TRIAL: ABDOMINAL VS LAPAROSCOPIC SACROPEXY FOR ADVANCED PELVIC ORGAN PROLAPSE 107
POLYVINYLIDENFLUORID (PVDF) AND POLYPROPYLENE MESH FOR SACROCOLPOPEXY: A COMPARATIVE STUDY 106
Disobstruction after RARP in low-risk prostate cancer: a case-control study 106
Is Valsalva Leak point pressure a reliable test? 105
Bladder and urethral sphincter function after radical retropubic prostectomy: 3 years follow up. 105
Iniezione intravescicale di tossina botulinica A nel trattamento della vescica ipersensibile 105
A Camey II Modified Neobladder: Long-Term Complications And Functional Results. 105
UROLOGIC LATENCY TIME (ULT) DURING UROFLOW STOP TEST WITH ELECTROMYOGRAPHY: A POST-RARP CONTINENCE DETECTOR 105
VALUTAZIONE ECOGRAFICA DELLE PAZIENTI SOTTOPOSTE AD INTERVENTO DI CORREZZIONE DELLA STATICA PELVICA CON IMPIEGO DI PROTESI 104
Botulinum-A toxin injections into the detrusor muscle reduce nerve growth factor bladder tissue levels in patients affected by neurogenic detrusor overactivity. 104
Bladder outlet obstruction in men with benign prostatic hypertrophy 104
Robotic treatment of oligometastatic kidney tumor with synchronous pancreatic metastasis: Case report and review of the literature 104
La colposospensione associata a ricostruzione integrale del pavimento pelvico 103
ESWL in Renal Stone Clearance from Calyxes 103
Affidabilità dell’ecografia nella diagnosi dell’ipermobilità uretrale: dati preliminari 103
Role of miRNAs in prostate cancer: Do we really know everything? 103
Ruolo della re-turb nei tumori vesciali superficiali ad altro rischio di progressione e recidiva. 102
BOTULINUM-A TOXIN INJECTIONS INTO THE DETRUSOR MUSCLE REDUCE NERVE GROWTH FACTOR BLADDER TISSUE LEVELS IN P A TIENTS AFFECTED BY NEUROGENIC DETRUSOR OVER- ACTIVITY 102
Bcg vs. Gemcitabina per la terapia endovescicale del carcinoma uroteliale ad alto rischio: Studio prospettico randomizzato 102
Bladder tissue levels of NGF in SCI patients with detrusor overactivity before and after botulinum-A toxin injections into the detrusor muscle 101
Botulinum Toxin A for Overactive Bladder and Detrusor Muscle Overactivity in Patients With Parkinson's Disease and Multiple System Atrophy 100
Preservazione dell'utero o isterectomia negli interventi di sacropessia per prolasso uterovaginale: due tecniche a confronto 99
Validation in an Independent Cohort of MiR-122, MiR-1271, and MiR-15b as Urinary Biomarkers for the Potential Early Diagnosis of Clear Cell Renal Cell Carcinoma 99
Profilassi con Plurifloxacina vs Fosfomicina in pawienti affette da cistiti ricorrenti. Risultati preliminari di uno studio randomizzato 98
Risultati chirurgici nelle donne in età avanzata 98
Burch colposuspension does not provide any additional benefit to pelvic organ prolapse repair in patients with urinary incontinence: A randomized surgical trial 97
Il q-tip test nella diagnosi di ipermobilità uretrale 97
Surgical outcome during post-graduated educational courses for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) repair: case control study 96
Nerve Growth Factor bladder tissue levels in patients with benign prostatic hyperplasia and detrusor overactivity treated with tamsulosin. 96
Female sexual function evaluation in patients who underwent integral pelvic floor reconstructive surgery 96
Trattamento endovescicale adiuvante del TCC superficiale ad alto rischio con mitomicina elettroindotta vs BCG. 96
Isterocolposacropessia:confronto tra videolaparoscopia e chirurgia open 96
Traumi della milza : nostra esperienza 96
ABDOMINAL VS LAPAROSCOPIC SACROCOLPOPEXY: A RANDOMIZED CONTROLLED TRIAL 96
Echo-color doppler in the diagnosis of vascular abnormalities associated with ureteropelvic junction obstruction 95
The management of pelvic organ prolapse. A review 95
Chirurgia del prolasso con preservazione dell’utero: risultati a lungo termine 95
Recurvatum congeniti ed acquisiti del pene 94
Preoperative urinary incontinence is the main risk factor for post-operative incontinence in women who underwent POP (Pelvic Organ Prolapse) repair 94
Pre and post-operative urodynamic patterns and continence in patients undergoing bladder-neck- sparing radical retro-pubic prostatectomy (RRP) 94
Relationships between voiding dysfunction and peripheral neuropathy in asymptomatic patients affected by diabetes mellitus type I: preliminary results. 93
Ricostruzione integrale del pavimento pelvico 93
TRATTAMENTO ENDOVESCICALE ADIUVENTE DEL TCC SUPERFICIALE AD ALTO RISCHIO CON MITOMICINA ELETTROINDOTTA VS BCG: NOSTRA ESPERIENZA 93
Detrusor overactivity and urogenital prolapse 93
TRATTAMENTO ENDOVESCICALE CON BCG Vs GEMCITABINA NELLA TERAPIA ADIUVANTE DEL TCC SUPERFICIALE AD ALTO E MEDIO RISCHIO. 93
Mini-invasive techniques for the treatment of female stress urinary incontinence 93
Totale 21.065
Categoria #
all - tutte 100.852
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.852


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021906 0 0 0 0 0 0 0 0 0 172 293 441
2021/20223.058 86 579 130 241 142 68 84 642 81 93 394 518
2022/20235.330 412 598 242 359 400 584 173 406 1.469 139 331 217
2023/20243.019 228 287 194 202 134 105 438 265 305 175 370 316
2024/20255.220 218 495 260 287 655 270 269 447 818 372 666 463
2025/20267.694 658 619 495 1.022 935 668 1.180 447 914 756 0 0
Totale 32.236